XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Shareholders' Equity Statement - USD ($)
$ in Thousands
Total
Registered direct offering
"At the market" equity offering
Common Stock
Common Stock
Registered direct offering
Common Stock
"At the market" equity offering
Accumulated Other Comprehensive Income (loss)
Accumulated Deficit
Non-Controlling Interest
Beginning Balance (in shares) at Dec. 31, 2023       4,760,557          
Beginning Balance at Dec. 31, 2023 $ 36,798     $ 486,324     $ 3,378 $ (477,161) $ 24,257
Stock issued under employee equity incentive plans (in shares)       56,719          
Stock issued under employee equity incentive plans 125     $ 125          
Stock-based compensation expense 1,075     $ 1,075          
Foreign currency translation adjustment 522           775   (253)
Net loss attributable to non-controlling interest (98)               (98)
Net income (loss) (5,066)             (5,066)  
Ending Balance (in shares) at Mar. 31, 2024       4,817,276          
Ending Balance at Mar. 31, 2024 33,356     $ 487,524     4,153 (482,227) 23,906
Beginning Balance (in shares) at Dec. 31, 2023       4,760,557          
Beginning Balance at Dec. 31, 2023 36,798     $ 486,324     3,378 (477,161) 24,257
Net income (loss) (23,356)                
Ending Balance (in shares) at Sep. 30, 2024       4,911,535          
Ending Balance at Sep. 30, 2024 15,649     $ 489,546     2,942 (500,517) 23,678
Beginning Balance (in shares) at Mar. 31, 2024       4,817,276          
Beginning Balance at Mar. 31, 2024 33,356     $ 487,524     4,153 (482,227) 23,906
Stock issued under employee equity incentive plans (in shares)       55,499          
Stock-based compensation expense 925     $ 925          
Foreign currency translation adjustment 175           260   (85)
Net loss attributable to non-controlling interest (298)               (298)
Net income (loss) (10,149)             (10,149)  
Ending Balance (in shares) at Jun. 30, 2024       4,872,775          
Ending Balance at Jun. 30, 2024 24,009     $ 488,449     4,413 (492,376) 23,523
Stock issued under employee equity incentive plans (in shares)       38,760          
Stock issued under employee equity incentive plans 55     $ 55          
Stock-based compensation expense 1,042     $ 1,042          
Foreign currency translation adjustment (996)           (1,471)   475
Net loss attributable to non-controlling interest (320)               (320)
Net income (loss) (8,141)             (8,141)  
Ending Balance (in shares) at Sep. 30, 2024       4,911,535          
Ending Balance at Sep. 30, 2024 15,649     $ 489,546     2,942 (500,517) 23,678
Beginning Balance (in shares) at Dec. 31, 2024       4,977,228          
Beginning Balance at Dec. 31, 2024 12,482     $ 490,619     4,693 (505,880) 23,050
Stock issued under employee equity incentive plans (in shares)       45,480          
Stock issued under employee equity incentive plans 29     $ 29          
Stock-based compensation expense 751     $ 751          
Foreign currency translation adjustment (137)           (252)   115
Offering (in shares)         164,176 59,165      
Offering   $ 1,341 $ 485   $ 1,341 $ 485      
Net loss attributable to non-controlling interest (259)               (259)
Net income (loss) (7,761)             (7,761)  
Ending Balance (in shares) at Mar. 31, 2025       5,246,049          
Ending Balance at Mar. 31, 2025 6,931     $ 493,225     4,441 (513,641) 22,906
Beginning Balance (in shares) at Dec. 31, 2024       4,977,228          
Beginning Balance at Dec. 31, 2024 12,482     $ 490,619     4,693 (505,880) 23,050
Net loss attributable to non-controlling interest (638)                
Net income (loss) (18,900)                
Ending Balance (in shares) at Sep. 30, 2025       5,626,878          
Ending Balance at Sep. 30, 2025 (1,152)     $ 497,204     3,644 (524,780) 22,780
Beginning Balance (in shares) at Mar. 31, 2025       5,246,049          
Beginning Balance at Mar. 31, 2025 6,931     $ 493,225     4,441 (513,641) 22,906
Stock issued under employee equity incentive plans (in shares)       63,147          
Stock-based compensation expense 739     $ 739          
Foreign currency translation adjustment (386)           (566)   180
Offering (in shares)           10,010      
Offering     73     $ 73      
Net loss attributable to non-controlling interest (218)               (218)
Net income (loss) (6,707)             (6,707)  
Fractional share adjustment due to reverse stock split (in shares)           157      
Ending Balance (in shares) at Jun. 30, 2025       5,319,363          
Ending Balance at Jun. 30, 2025 432     $ 494,037     3,875 (520,348) 22,868
Stock issued under employee equity incentive plans (in shares)       29,131          
Stock issued under employee equity incentive plans 19     $ 19          
Stock-based compensation expense 754     $ 754          
Foreign currency translation adjustment (158)           (231)   73
Offering (in shares)           278,384      
Offering     $ 2,394     $ 2,394      
Net loss attributable to non-controlling interest (161)               (161)
Net income (loss) (4,432)             (4,432)  
Ending Balance (in shares) at Sep. 30, 2025       5,626,878          
Ending Balance at Sep. 30, 2025 $ (1,152)     $ 497,204     $ 3,644 $ (524,780) $ 22,780